Sahpra

28/05/2026

🔬 What are “peptides”?

Think of them as tiny building blocks your body uses to make proteins — helping to construct and repair different parts of your body.

They occur naturally in the body and play an important role in functions like hormones, healing, and communication between cells.

Some products made from these building blocks are being marketed for weight loss, muscle building, anti-ageing and performance enhancement. However, not all of these products are registered or tested for safety.

⚠️ Always be cautious and speak to a healthcare professional before using any of these products.

For more information, visit www.sahpra.org.za

26/05/2026

📢 SAHPRA Vacancy Alert!

The South African Health Products Regulatory Authority (SAHPRA) invites applications for the position of:

Radiation Inspector: Durban Office
(Fixed-term contract until 31 March 2028)

🗓 Closing date: 8 June 2026

Be part of an organisation committed to protecting public health and ensuring radiation safety in South Africa.

🔗 Find out more and apply: https://bit.ly/41uX9Uk

26/05/2026

🚨 Public Warning: Know What You’re Using

Thinking about using peptides for weight loss, muscle gain, or anti-ageing? Make informed choices about your health.
SAHPRA cautions against the growing use of unregistered peptide products, which may not be tested for safety, quality, or effectiveness — putting you at risk.

✅ Always consult a healthcare professional
✅ Only use medicines from authorised providers

Watch to learn more: https://youtu.be/HyMFGmA7ZIg

24/05/2026

⚠️ Public Safety Alert: Unregistered Weight-Loss Medicines Seized ⚠️

The South African Health Products Regulatory Authority (SAHPRA), working with the South African Pharmacy Council (SAPC), has taken strong action against the unlawful manufacture and distribution of unregistered GLP-1 medicines used for weight loss.

An inspection at a facility in Pretoria uncovered serious violations, including:
👉️ Illegal large-scale manufacturing under the guise of “compounding”
👉️ Use of untested and illegally imported active ingredients
👉️ Poor sterile conditions and lack of quality controls
👉️ No systems in place to monitor adverse reactions

Several injectable products, including those containing semaglutide and tirzepatide, have been seized, and a full product recall has been initiated. Reports of adverse events, including hospitalisations, have also been noted.

🚫 The use, sale, or promotion of unregistered medicines is illegal and poses a serious risk to public health.

✅ Members of the public are advised to consult qualified healthcare professionals for safe and approved treatment options.

🔗 Find out more: https://bit.ly/3RWa1BS

22/05/2026

Early this week, SAHPRA launched the Online Medicine Directory, reflecting our commitment to innovation, transparency and patient-centred regulation. By leveraging digital technology, we are increasing public access to critical medicine information and strengthening confidence in South Africa’s healthcare system.

Visit the Online Medicines Directory - https://medsinfo.sahpra.org.za

13/05/2026

📢 SAHPRA is Hiring!

The South African Health Products Regulatory Authority (SAHPRA) invites applications for the following vacancies:

• Senior Manager: Medical Devices and Radiation Control (Re-advertisement)
• Medicines Control Officer: Investigations Grade 1 (x2)
• Medicines Control Officer: Traceability Grade 1 (x2)
• Medicines Control Officer: Post Market Surveillance Grade 1 (x2)
• Medicines Control Officer: Control of Import Authorisations and Inspections Grade 1 (x2)
• Medicines Control Officer: Control of Promotions, Marketing Materials and Adverts Grade 1 (x2)
• Import Approval Medicines Control Technician (x6)

Be part of an organisation dedicated to safeguarding public health in South Africa. 🇿🇦💊

🔗 Find out more and apply: https://bit.ly/41uX9Uk

13/05/2026

🚨 CALL FOR EXPRESSION OF INTEREST 🚨
Good Manufacturing Practice (GMP) External Evaluators

The South African Health Products Regulatory Authority invites qualified professionals to submit expressions of interest to serve as External Evaluators within the Inspectorate Unit.

🔗 Apply here: https://apply.sahpra.org.za:6006/

⏰ Closing Date: Friday, 29 May 2026 at 16h30

Join us in strengthening regulatory excellence and ensuring the quality, safety, and efficacy of health products in South Africa.

12/05/2026

📢 Join Our Upcoming SAHPRA Webinar!

The South African Health Products Regulatory Authority (SAHPRA) invites industry stakeholders to a focused webinar on Medical Device Licensing and Compliance.

This session will provide key guidance on regulatory requirements and support improved compliance across the sector.

🗓 Date: 22 May 2026
⏰ Time: 10:00 – 12:00

Topics include:
✅ Application process updates
✅ ISO 13485 certification progress
✅ Annual retention fees
✅ Port of entry requirements

🔗 Register here: https://bit.ly/4dEc06g

Don’t miss this opportunity to stay informed and aligned with SAHPRA requirements.

11/05/2026

📢 SAHPRA is Hiring!

The South African Health Products Regulatory Authority (SAHPRA) invites applications for the following vacancies:

• Deputy Manager: ICT Business Applications and Systems
• Desktop Technician
• Senior Manager: Laboratory Services
• Technical Screener: Health Products Authorisations

Be part of an organisation committed to safeguarding public health in South Africa.

🔗 Find out more and apply: https://bit.ly/41uX9Uk

Welcome to our Expression of Interest portal! Our platform offers a wide range of opportunities across various industries and locations. Our easy-to-use interface allows you to search for Expression of Interest, create a profile, and apply with just a few clicks. Sign up today and take the first ste...

28/04/2026

🤖 Open Tender Alert!

SAHPRA is inviting bids to engage an AI Technology Consultant for a 36-month term, with an option to renew for an additional 24 months.

📅 Closing date: 21 May 2026 at 11:00
🔗 Find out more: https://bit.ly/3UrA7fB